Porcilis® Glässer Suspension for injection for pigs
Porcilis Glässer is a vaccine used for active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5. The vaccine is of benefit when animals with no or low levels of antibodies against H. parasuis serotype 5 are mixed with pigs from or in an environment with a high prevalence of Glässer’s disease.
Presentation
Aqueous, white or nearly white suspension for injection
Active ingredients
Per 2 ml dose:
- Inactivated whole bacterial cells of Haemophilus parasuis serotype 5, strain 4800: 0.05 mg total nitrogen, inducing ≥ 9.1 Elisa Units*.
- Adjuvant: 150 mg dl-α-tocopheryl acetate.
* ELISA units = mean antibody titre (log2 value) in the potency test in mice.
Target species
Pigs and Sows
Indications for use
Pigs
Active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5.
Onset of immunity: 2 weeks after completion of vaccination.
Duration of immunity: 14 weeks after completion of vaccination.
Sows
For passive immunisation of the progeny of vaccinated sows and gilts to reduce infection, mortality, clinical signs and typical lesions of Glässer disease caused by H. parasuis serotype 5 and to reduce clinical signs and mortality caused by H. parasuis serotype 4.
Onset of immunity: After birth and sufficient uptake of colostrum.
Duration of immunity has been demonstrated at 4 weeks of age against serotype 4 and at 6 weeks of age against serotype 5.
Withdrawal periods
Pigs – meat: zero days
Packaging
50 ml (25 doses) Glass type I or PET vials
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: February 2025